Medisafe: Funding, Investors & Team (Sep 2026)

Medisafe is a digital patient engagement platform, empowering patients to stay on top of all their medications. Its approach leverages the billions of data points collected to personalize patient engagement and improve adherence and persistence to medications. By addressing the major challenges of medication management utilizing a data science-driven approach, Medisafe improves patient adherence and quality of care. The company provides its pharma and payer partners the opportunity to engage each patient on an individual level, supporting them throughout the entire patient journey, and provides unique insights on behavior patterns critical for improving the patient experience. Medisafe had shown over numerous studies, both retrospective with tens of thousands of patients as well as RCTs, that its solutions improve adherence by up to 20%. Founded following an accidental insulin overdose of the founder's father, the Medisafe solution currently has nearly 5 million registered users across iOS and Android smartphones, tablets, wearables, and Web solutions, who have recorded over 2 billion medication doses. Nearly 200,000 users have rated the app an average of 4.7 out of 5 stars in the App Store and Google Play store, making it the Top Rated solution in the category. Their accolades include Gartner Cool Vendors, Traction winner (Health 2.0 startup competition), Fast Company Most Innovative in Healthcare, Google and Apple Editors' Choice and Top Developer, etc.

Medisafe has raised $30.0M across 1 round on record. The most recent is a Series C of $30.0M announced in Feb 2021.

Medisafe's most recent funding round on record is a Series C of $30.0M, announced in Feb 2021.

Omri Shor is listed as CEO at Medisafe.

Medisafe is based in Boston, Massachusetts, United States.

Medisafe is in the 51-100 employee band.

Medisafe's latest round of $30.0M is above the $4.3M median round size for Apps companies on FundedIQ across 2,426 tracked companies over the last two years.